CNBCPfizer cuts 2022 earnings outlook despite strong first-quarter Covid vaccine and antiviral salesMay 3, 2022Spencer KimballBy Spencer Kimballmore_vert
The GuardianPfizer accused of Covid profiteering as first-quarter sales hit $26bnMay 3, 2022Julia KolleweBy Julia Kollewemore_vert